澳大利亚 Carotid Revascularization 的变化趋势:一项超过 30 年的全国性研究
David F Sun1, Kevin Tian1, Amanda Seneviratne1
1The Department of Vascular and Endovascular Surgery, Townsville University Hospital, Townsville, Queensland, Australia.
ANZ journal of surgery
|May 12, 2025
概括
在过去的30年里,动脉复血管化手术,包括动脉内关节切除术 (CEA) 和动脉支架 (CAS),已经减少了. CEA的下降幅度较大,但仍然比CAS更为普遍,反映了医疗治疗的变化.
科学领域:
- 血管外科 血管外科
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 动脉狭窄是急性缺血性中风的重要危险因素.
- 冠状动脉内关节切除术 (CEA) 和冠状动脉支架 (CAS) 是冠状动脉再血管化的主要干预措施.
- 了解程序趋势对于医疗保健计划至关重要.
研究的目的:
- 调查澳大利亚动脉复血管化手术的30年趋势.
- 分析随着时间的推移,CEA与CAS的利用变化.
主要方法:
- 利用来自澳大利亚卫生与福利研究所 (AIHW) 和澳大利亚医疗保险的人口级数据.
- 在1993年至2024年期间接受CEA或CAS的确定的患者.
- 分析了30年研究期间的程序量和趋势.
主要成果:
- 整体上,动脉复血管化手术减少,CEA显著下降 (47.4%51.0%).
- CAS程序显示AIHW数据集的相对增加 (23.1%),但Medicare数据集略有下降.
- 尽管下降,CEA程序仍然比CAS程序更常见.
结论:
- 在过去的30年里,动脉复血管化手术的发生率稳步下降.
- 与CAS相比,CEA的较大减少表明了治疗偏好或患者选择的转变.
- 随着动脉疾病的医学治疗方法的发展,这些程序趋势可能会受到影响.
更多相关视频
06:53A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
4.9K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.2K
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
